A New Treatment Method in Hepatocellular Carcinoma by MicroRNAs

Zahra Asefy; Behrooz Shokuhi; Alireza Abhari; Zeinab Latifi; Saeed Nazari Soltan Ahmad; Naser Samadi; Sirus Hoseinnejhad; Asgar Tanomand; Mohammad Nouri

E-ISSN : 2148-9696

Crescent Journal of
Medical and Biological Sciences

Main Page Aim and Scope Instructions to Authors Editorial Policies Editorial Board Authorship Agreement Form Open Access and Copyright

Oct 2020, Vol 7, Issue 4

CURRENT ISSUE ARCHIVE AHEAD OF PRINT / ACCEPTED ARTICLE MOST VIEWED ARTICLES NEWS RELATED LINKS

Advanced Search

For Author's & Reviewer's

Committee on Publication
Ethics (COPE) Flowchart

Recommendations for the Conduct

World Association of Medical Editors(WAME)

EQUATOR Resources : Reviewers

Poll

How do you find the scientific quality of the published articles on our web site?

Very good

Good

Fair

Bad

Very bad

Review
A New Treatment Method in Hepatocellular Carcinoma by MicroRNAs
Zahra Asefy^1,2,3,4, Behrooz Shokuhi¹, Alireza Abhari², Zeinab Latifi², Saeed Nazari Soltan Ahmad², Naser Samadi², Sirus Hoseinnejhad⁴, Asgar Tanomand⁴, Mohammad Nouri^1,2
¹Liver and Gastrointestinal Diseases Research Center, Tabriz University of Medical Sciences, Tabriz, Iran ²Department of Biochemistry and Clinical Laboratories, Tabriz University of Medical Sciences, Tabriz, Iran ³Student’s Research Committee, Tabriz University of Medical Sciences, Tabriz, Iran ⁴Maragheh University of Medical Sciences Maragheh, Iran
CJMB 2020; 7: 451-456 Viewed : 2637 times Downloaded : 2252 times. Keywords : Hepatocellular carcinoma, miRNA, Molecular targets
Full Text(PDF) \| Related Articles
Abstract

Objectives: Hepatocellular carcinoma (HCC) is considered as the most incidence form of cancer in the human liver and the main reason for worldwide cancer death. In addition, HCC is a common form of cancer in Africa and Asia and a global health issue. Thus, efforts should be made to improve treatment strategies and prognosis in HCC for recognizing novel prognostic and predictive markers. Methods: The present study reviewed recently published studies that were identified from the National Institutes of Health"s PubMed database, Latin American Literature in Health Sciences, and Scientific Electronic Library Online. To this end, several key terms were searched, including "hepatocellular carcinoma" AND "diagnosis" AND "hepatic resection", miRNA, and Mesh (Medical Subject Headings) consisting of miRNA "hepatocellular carcinoma". Results: Both physiological and pathological processes such as development can be altered by the function and expression modifying of miRNA. The findings revealed that miR-101, miR-106, miR-130a, miR-515-5p, miR-199a, and miR-34a-5p have a considerable connection with tumor size in HCC patients. Conclusions: In general, several reports indicated that more than half of the miRNAs genes are located in cancer-associated genomic regions or fragile sites. Considering the reports regarding the important roles of miRNAs in cancer, their potential as prognostic or diagnostics markers is confirmed by a long list of studies and miRNA markers that could be used for cancer diagnosis are becoming available